ImmunityBio, Inc.
DE ˙ XTRA ˙ US45256X1037
6,13 € ↓ -0,20 (-3,16%)
2026-06-05
DEL PRIS
SecurityDE:26CA / ImmunityBio, Inc.
InstitutionSG Americas Securities, LLC
Latest Disclosed Ownership37,790 shares
Latest Disclosed Value $ 290
SG Americas Securities, LLC reports 23.03% decrease in ownership of 26CA / ImmunityBio, Inc.

On April 16, 2026 - SG Americas Securities, LLC filed a 13F-HR form disclosing ownership of 37,790 shares of ImmunityBio, Inc. (DE:26CA) valued at $247,902 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 9, 2026 disclosing 49,097 shares of ImmunityBio, Inc.. The current value of the position is $231,653 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-16 2026-03-31 13F IMMUNITYBIO INC COM COM 45256X103 37,790 -11,307 -23.03 0 0.0003
2026-01-09 2025-12-31 13F IMMUNITYBIO INC COM COM 45256X103 49,097 18,791 62.00 0 0.0001
2025-10-23 2025-09-30 13F IMMUNITYBIO INC COM COM 45256X103 30,306 30,306 0 0.0003
2025-08-08 2025-06-30 13F IMMUNITYBIO INC COM COM 45256X103 0 -42,188 -100.00 0 0.0000
2025-04-15 2025-03-31 13F IMMUNITYBIO INC COM COM 45256X103 42,188 -18,152 -30.08 0 0.0004
2025-01-17 2024-12-31 13F IMMUNITYBIO INC COM COM 45256X103 60,340 565 0.95 0 0.0006
2024-10-03 2024-09-30 13F IMMUNITYBIO INC COM COM 45256X103 59,775 59,775 0 0.0008
2024-05-06 2024-03-31 13F IMMUNITYBIO INC COM COM 45256X103 0 -49,005 -100.00 0 0.0000
2024-01-12 2023-12-31 13F IMMUNITYBIO INC COM COM 45256X103 49,005 15,308 45.43 0 0.0023
2023-10-13 2023-09-30 13F IMMUNITYBIO INC COM COM 45256X103 33,697 33,697 0 0.0007
2023-07-10 2023-06-30 13F IMMUNITYBIO INC COM COM 45256X103 0 -51,013 -100.00 0 0.0000
2023-04-28 2023-03-31 13F IMMUNITYBIO INC COM COM 45256X103 51,013 33,613 193.18 0 0.0011
2023-02-02 2022-12-31 13F IMMUNITYBIO INC COM COM 45256X103 17,400 -80,262 -82.18 0 -100.00 0.0011
2022-10-31 2022-09-30 13F IMMUNITYBIO INC COM COM 45256X103 97,662 256 0.26 485 33.98 0.0060
2022-07-29 2022-06-30 13F IMMUNITYBIO INC COM COM 45256X103 97,406 47,410 94.83 362 29.29 0.0039
2022-04-29 2022-03-31 13F IMMUNITYBIO INC COM COM 45256X103 49,996 23,617 89.53 280 75.00 0.0021
2022-02-07 2021-12-31 13F IMMUNITYBIO INC COM COM 45256X103 26,379 -51,006 -65.91 160 -78.78 0.0009
2021-11-01 2021-09-30 13F IMMUNITYBIO INC COM COM 45256X103 77,385 45,125 139.88 754 63.56 0.0035
2021-08-12 2021-06-30 13F IMMUNITYBIO INC COM COM 45256X103 32,260 19,340 149.69 461 50.16 0.0021
2021-05-13 2021-03-31 13F IMMUNITYBIO INC COM COM 45256X103 12,920 2,789 27.53 307 127.41 0.0016
2021-02-04 2020-12-31 13F NANTKWEST INC COM COM 63016Q102 10,131 10,131 135 0.0007
2020-11-09 2020-09-30 13F NANTKWEST INC COM COM 63016Q102 0 -15,635 -100.00 0 -100.00
2020-07-20 2020-06-30 13F NANTKWEST INC COM COM 63016Q102 15,635 15,635 192 0.0016
2019-04-29 2019-03-31 13F NANTKWEST INC COM COM 63016Q102 0 -42,111 -100.00 0 -100.00
2019-01-31 2018-12-31 13F NANTKWEST INC COM COM 63016Q102 42,111 42,111 49 0.0004
2018-08-07 2018-06-30 13F NANTKWEST INC COM COM 63016Q102 0 -21,812 -100.00 0 -100.00
2018-05-03 2018-03-31 13F NANTKWEST INC COM COM 63016Q102 21,812 21,812 85 0.0007
2018-01-24 2017-12-31 13F NANTKWEST INC COM COM 63016Q102 0 -49,356 -100.00 0 -100.00
2017-11-07 2017-09-30 13F NANTKWEST INC COM COM 63016Q102 49,356 35,424 254.26 270 154.72 0.0024
2017-08-03 2017-06-30 13F NANTKWEST INC COM COM 63016Q102 13,932 -13,104 -48.47 106 10.42 0.0010
2017-05-10 2017-03-31 13F NANTKWEST INC COM COM 63016Q102 27,036 -1,639 -5.72 96 -41.46 0.0008
2017-02-08 2016-12-31 13F NANTKWEST INC COM COM 63016Q102 28,675 28,675 164 0.0014
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.